Methamphetamine.
Conditions
Interventions
Intervention group: 84 patients referred to Golestan hospital clinic, who were diagnosed by a psychiatric specialist based on DSM V diagnosis criteria, entered the study and were randomly assigned to
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: At least one positive urine test for methamphetamine during the hospitalization period Absence of current acute illness Absence of serious chronic diseases Able and willing to provide informed consent and adhere to the visit schedule
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decreasing addiction in patients using amphetamine and methamphetamine. Timepoint: Before starting the treatment, at the beginning of the treatment and once every two weeks (the length of the treatment is 12 weeks), the results will be measured. Method of measurement: With physical examinations and measurement of vital signs, evaluation with the dependency index questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reducing depression in patients using amphetamine and methamphetamine. Timepoint: Before starting the treatment, at the beginning of the treatment and once every two weeks (the length of the treatment is 12 weeks), the results will be measured. Method of measurement: with Beck depression questionnaire, physical examinations and measuring vital signs. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Hossein Salehi Kasai
Ahvaz University of Medical Sciences
Outcome results
None listed